Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: Tumor tissue levels of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) and outcome following adjuvant chemotherapy in premenopausal lymph node-positive breast cancer patients: A retrospective study

Figure 1

Kaplan-Meier plot showing the DFS (A) and OS (B) of untreated TIMP-1 low and high patients. The median TIMP-1 concentration of the total patient group (12.5 ng/mg of total protein) was used as cut point (TIMP-1 low patients N = 57, TIMP-1 high patients N = 45). Cox univariate regression analysis; DFS: HR 0.93, 95% CI 0.58-1.49, P = 0.76; OS: HR 0.72, 95% CI 0.39-1.33, P = 0.30.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us